Literature DB >> 22457437

Evaluation of Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in scleroderma patients.

Antonietta Gigante1, Edoardo Rosato, Rita Massa, Carmelina Rossi, Biagio Barbano, Rosario Cianci, Ilenia Molinaro, Antonio Amoroso, Felice Salsano.   

Abstract

OBJECTIVE: Renal involvement in SSc is often subclinical and chronic kidney disease (CKD) develops, with slow worsening of glomerular filtration rate (GFR). The present investigation was undertaken in order to study how well the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) correlates with measured GFR (mGFR) in a group of SSc patients with serum creatinine (sCr) in the normal range.
METHODS: Forty-one scleroderma patients (37 females and 4 males) with a median age of 46 years were enrolled. GFR was measured using technetium-99 m DTPA (Tc-99 m DTPA). The modified Cockroft-Gault formula, 4- and 7-variable Modification of Diet in Renal Disease (MDRD) and CKD-EPI equations were used for estimated GFR (eGFR).
RESULTS: mGFR showed a median value of 84 ml/min (range 32.8-121.2 ml/min). Seven patients had reduced GFR (<60 ml/min), 19 had GFR within 60-90 ml/min and 15 had GFR >90 ml/min. The results showed mild correlation between the BSA-modified Cockroft-Gault and mGFR (P > 0.05), mild statistically significant correlation with 4-variable MDRD (P < 0.05), high statistically significant correlation with 7-variable MDRD (P = 0.01), but the greatest correlation was obtained using CKD-EPI (P = 0.002). No correlation with age, disease duration or subset of disease was found.
CONCLUSIONS: In scleroderma patients with normal sCr value, CKD-EPI is a useful formula to assess GFR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457437     DOI: 10.1093/rheumatology/kes049

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

1.  Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward.

Authors:  Antonietta Gigante; Marta Liberatori; Maria Ludovica Gasperini; Liborio Sardo; Francesca Di Mario; Barbara Dorelli; Biagio Barbano; Edoardo Rosato; Filippo Rossi Fanelli; Antonio Amoroso
Journal:  Cardiorenal Med       Date:  2014-05-06       Impact factor: 2.041

2.  Increased serum uric acid levels are associated with digital ulcers in patients with systemic sclerosis.

Authors:  Eunsung Kim; Han-Na Lee; Yun-Kyung Kim; Geun-Tae Kim; Min Wook So; Eunyoung Ahn; Dong Hyun Sohn; Seung-Geun Lee
Journal:  Rheumatol Int       Date:  2019-01-17       Impact factor: 2.631

Review 3.  Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

Authors:  Cosimo Bruni; Giovanna Cuomo; Francesca W Rossi; Emanuela Praino; Silvia Bellando-Randone
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

4.  Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis.

Authors:  Antonietta Gigante; Giuseppe Barilaro; Biagio Barbano; Antonella Romaniello; Francesca Di Mario; Silvia Quarta; Maria Ludovica Gasperini; Gianluca Di Lazzaro Giraldi; Alessandro Laviano; Antonio Amoroso; Rosario Cianci; Edoardo Rosato
Journal:  Cardiorenal Med       Date:  2016-01-23       Impact factor: 2.041

5.  Serum level of endostatin and digital ulcers in systemic sclerosis patients.

Authors:  Antonietta Gigante; Domenico Margiotta; Luca Navarini; Biagio Barbano; Maria L Gasperini; Claudia D'Agostino; Antonio Amoroso; Antonella Afeltra; Edoardo Rosato
Journal:  Int Wound J       Date:  2018-03-30       Impact factor: 3.315

Review 6.  Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

7.  Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.

Authors:  Antonietta Gigante; Chiara Pellicano; Giorgia Leodori; Cecilia Napodano; Lorenzo Vantaggio; Francesca Gulli; Mariapaola Marino; Marcella Visentini; Edoardo Rosato; Umberto Basile
Journal:  Clin Exp Immunol       Date:  2021-06-02       Impact factor: 5.732

8.  Erythrocyte glutathione transferase: a non-antibody biomarker for systemic sclerosis, which correlates with severity and activity of the disease.

Authors:  R Fabrini; E Rosato; A Gigante; A Bocedi; R Cianci; B Barbano; E Del Grosso; F Ricci; V Zingaretti; F Salsano; G Ricci
Journal:  Cell Death Dis       Date:  2013-07-25       Impact factor: 8.469

9.  Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients - a 24-month observation.

Authors:  Ewa Wielosz; Maria Majdan; Arkadiusz Koszarny; Magdalena Dryglewska; Jacek Tabarkiewicz
Journal:  Cent Eur J Immunol       Date:  2017-08-08       Impact factor: 2.085

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.